December 25, 2014 | The CEO of Brainsway, an Israeli company developing treatments for serious brain disorders, Uzi Sofer will step down from his position. Sofer informed the company and its investors of his decision this morning (Thursday), with the company agreeing that he will end his term at Brainsway in April 2015 after 12 years serving as the head of the company he founded. Sofer will remain the director of the company. Brainsway also announced that it will cut ties with its public relations representatives in the United States, reaching the decision that it will begin its own marketing regime in the US. According to most estimates, the company seeks out an American CEO to replace Sofer that will help the company get on its feet in the US. Recently, the company received FDA approval for the treatment of depression using its Deep TMS System. Brainsway was founded in 2003 by Uzi Sofer, President Avner Hagai and Chairman David Zacut.